Although TET1-MLL translocation was observed in acute myeloid leukemia (AML) as early as 2003 [6], the exact biochemical activity of TET proteins and their functional roles have been extensively studied since 2009 (Figure 1). Here, KMT2A is linked to acute myeloid leukemia.